We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Corticosteroids for Acute Migraine in the Emergency Department

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02847494
First Posted: July 28, 2016
Last Update Posted: December 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Benjamin Friedman, Montefiore Medical Center
  Purpose
This is an emergency department based randomized trial in which we compare two different treatment for migraine headache. The goal is to decrease the number of headache days during the week after ED discharge.

Condition Intervention Phase
Migraine Drug: metoclopramide Drug: Dexamethasone Drug: methylprednisolone acetate Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial

Resource links provided by NLM:


Further study details as provided by Benjamin Friedman, Montefiore Medical Center:

Primary Outcome Measures:
  • Headache days [ Time Frame: 1 week ]
    Number of days with headache during the week following emergency department discharge


Secondary Outcome Measures:
  • Sustained headache freedom [ Time Frame: 1 week ]
    No headache at all during the week following emergency department discharge

  • Preference [ Time Frame: 1 week ]
    Do you want to receive the same medication during a subsequent visit to the emergency department


Enrollment: 220
Actual Study Start Date: September 1, 2016
Study Completion Date: September 30, 2017
Primary Completion Date: September 21, 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Control
Metoclopramide 10mg IV+ dexamethasone 10mg IM
Drug: metoclopramide
metoclopramide 10mg intravenous infusion over 15 minutes
Drug: Dexamethasone
dexamethasone 10mg intramuscular injection
Active Comparator: Experimental
Metoclopramide 10mg IV + methylprednisolone acetate 160mg IM
Drug: metoclopramide
metoclopramide 10mg intravenous infusion over 15 minutes
Drug: methylprednisolone acetate
methylprednislone acetate 160mg intramuscular injection

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Migraine without aura criteria (International Classification of Headache Disorders 3B )
  • Headache rated as moderate or severe in intensity

Exclusion Criteria:

  • Concern for secondary cause of headache
  • Contra-indications to investigational medications
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02847494


Locations
United States, New York
Montefiore Medical Center--Einstein
Bronx, New York, United States, 10461
Montefiore Medical Center-Moses
Bronx, New York, United States, 10467
Sponsors and Collaborators
Montefiore Medical Center
Investigators
Principal Investigator: Benjamin W Friedman, MD, MS Albert Einstein College of Medicine, Inc.
  More Information

Responsible Party: Benjamin Friedman, PI, Montefiore Medical Center
ClinicalTrials.gov Identifier: NCT02847494     History of Changes
Other Study ID Numbers: 2016-6342
First Submitted: July 25, 2016
First Posted: July 28, 2016
Last Update Posted: December 12, 2017
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Dexamethasone acetate
Prednisolone acetate
Methylprednisolone acetate
Dexamethasone
Methylprednisolone
Methylprednisolone Hemisuccinate
Prednisolone
Metoclopramide
Prednisolone hemisuccinate
Prednisolone phosphate
BB 1101
Anti-Inflammatory Agents
Antiemetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Protease Inhibitors
Enzyme Inhibitors